AstraZeneca dividend and valuation

AZN · LSE · GBp

Compare AstraZeneca
14,034.00 GBpChange from previous close: +0.37%Absolute change: +52.00 GBp

Close · November 16, 2026

Valuation

AstraZeneca paid 239.00 GBp per share in dividends over the last 12 months (yield 1.7%). Last ex-dividend date: August 6, 2026. The P/E ratio is 26.5. The average price target of 22 analysts is 16,299.70 GBp.

Data as of November 16, 2026

AstraZeneca compared with similar companies

AstraZeneca's P/E (trailing 12 months): 26.5, +24% against the median of a group of 10 similar companies (21.5).

AstraZeneca's metrics compared with similar companies
MetricAstraZenecaMedian25th–75th percentileBand
P/E (trailing 12 months)26.521.518.2 – 26.1High
Forward P/E16.513.110.9 – 15.9High
EV/EBITDA11.411.08.26 – 11.9Middle
Price/book5.624.652.17 – 6.94Middle
Price/sales3.483.482.03 – 4.19Middle
Gross margin81.8%73.8%67.3% – 74.7%High
Operating margin25.8%30.5%20.6% – 33.6%Middle
Net margin17.7%17.5%9.3% – 19.3%Middle
ROE22.6%24.3%10.5% – 33.2%Middle
Debt/equity0.660.910.46 – 1.20Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
£216.85B
Enterprise value
£243.11B
PEG
1.34
EV/revenue
3.90

Profitability and growth

ROA
8.6%
ROIC
17.2%
Revenue growth (year over year)
6.7%
Earnings growth (year over year)
23.5%

Financial health

Total cash
£8.17B
Total debt
£34.33B
Current ratio
1.01
Quick ratio
0.79
Altman Z-Score
3.60
Piotroski F-Score
6.00

Dividends

Annual dividend per share
239.00 GBp
Dividend yield
1.7%
Payout ratio
45.4%
Ex-dividend date
August 6, 2026

Analysts and estimates

Average price target
16,299.70 GBp
Median price target
16,325.23 GBp
High price target
20,801.73 GBp
Low price target
12,128.78 GBp
Analysts with a price target
22
Consensus
Buy
Forward EPS
849.12 GBp
EPS estimate, current year
1,024.43 GBp

Shares and trading

Beta
0.16
Average volume
2.82M
Shares outstanding
1.55B
Float
1.54B
Institutional ownership
66.4%
Insider ownership
0.3%